Stratification of Anatomical Imaging Features Between High-Risk and Non-High-Risk Groups in Neuroblastoma

被引:0
作者
Wang, Haoru [1 ]
Chen, Xin [1 ]
He, Ling [1 ]
Cai, Jinhua [1 ]
机构
[1] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Radiol,Childrens Hosp,Chongqing Key Lab Child, Minist Educ Key Lab Child Dev & Disorders, 136 Zhongshan Rd 2, Chongqing 400014, Peoples R China
关键词
children; computed tomography; image-defined risk factors; magnetic resonance imaging; neuroblastoma; CLASSIFICATION-SYSTEM; SINGLE;
D O I
10.1177/10732748251315883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study compared anatomical imaging features between high-risk and non-high-risk groups in neuroblastoma with at least one image-defined risk factor (IDRF). It also assessed the diagnostic performance of these features in identifying the high-risk group. Methods: A retrospective analysis of neuroblastoma patients with at least one IDRF was conducted. Imaging features, including estimated tumor volume and IDRFs, were compared between the two groups. The diagnostic performance of these features was assessed using receiver operating characteristic (ROC) curves, and the areas under the ROC curves (AUCs) along with their 95% confidence intervals (CIs) were calculated. Additionally, to internally validate their diagnostic performance, the bootstrap resampling method with 1000 bootstrap resamples was employed. Results: The study included 255 patients (185 high-risk cases, 70 non-high-risk cases). Significant differences were found in estimated tumor volume and IDRF number between the high-risk and non-high-risk groups (P < 0.001). The estimated tumor volume and the IDRF number-based cluster were independent risk factors, and their combination achieved an AUC of 0.801 (95% CI: 0.747-0.848) for high-risk group diagnosis, with the average AUC of the 1000 bootstrap samples of 0.800 (95% CI: 0.798-0.802). In abdominal lesions, specific IDRF categories differed between high-risk and non-high-risk groups (P < 0.05). Conclusion: Our study reveals anatomical imaging differences between high-risk and non-high-risk groups in neuroblastoma with at least one IDRF.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Mouse models of high-risk neuroblastoma
    Alvin Kamili
    Caroline Atkinson
    Toby N. Trahair
    Jamie I. Fletcher
    Cancer and Metastasis Reviews, 2020, 39 : 261 - 274
  • [22] HIGH-RISK NEUROBLASTOMA: A Therapy in Evolution
    Fong, Abraham
    Park, Julie R.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2009, 26 (08) : 539 - 548
  • [23] Venous Thrombosis and Procoagulant Factors in High-risk Neuroblastoma
    Schiavetti, Amalia
    Foco, Micaela
    Chiriaco, Damiano
    Iacobini, Metello
    Varrasso, Giulia
    Ingrosso, Annapaola
    Conti, Laura
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (02) : 93 - 96
  • [24] Oxaliplatin and Doxorubicin for Relapsed or Refractory High-Risk Neuroblastoma
    Tran, Hung C.
    Marachelian, Araz
    Venkatramani, Rajkumar
    Jubran, Rima F.
    Mascarenhas, Leo
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2015, 32 (01) : 26 - 31
  • [25] Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma
    Lucas, John Thomas, Jr.
    Wakefield, Daniel Victor
    Doubrovin, Michael
    Li, Yimei
    Santiago, Teresa
    Federico, Sara Michele
    Merchant, Thomas E.
    Davidoff, Andrew M.
    Krasin, Matthew J.
    Shulkin, Barry L.
    Santana, Victor M.
    Furman, Wayne Lee
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 34 : 42 - 50
  • [26] Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study
    Morgenstern, Daniel A.
    Poetschger, Ulrike
    Moreno, Lucas
    Papadakis, Vassilios
    Owens, Cormac
    Ash, Shifra
    Pasqualini, Claudia
    Luksch, Roberto
    Garaventa, Alberto
    Canete, Adela
    Elliot, Martin
    Wieczorek, Aleksandra
    Laureys, Genevieve
    Kogner, Per
    Malis, Josef
    Ruud, Ellen
    Beck-Popovic, Maja
    Schleiermacher, Gudrun
    Valteau-Couanet, Dominique
    Ladenstein, Ruth
    PEDIATRIC BLOOD & CANCER, 2018, 65 (11)
  • [27] Aortic intramural hematoma: Review of high-risk imaging features
    Kruse, Matthew J.
    Johnson, Pamela T.
    Fishman, Elliot K.
    Zimmerman, Stefan L.
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2013, 7 (04) : 267 - 272
  • [28] Telomere maintenance is pivotal for high-risk neuroblastoma
    Hertwig, Falk
    Peifer, Martin
    Fischer, Matthias
    CELL CYCLE, 2016, 15 (03) : 311 - 312
  • [29] Prolonged Isotretinoin in Ultra High-Risk Neuroblastoma
    Cash, Thomas
    Alazraki, Adina
    Qayed, Muna
    Katzenstein, Howard M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (01) : E33 - E35
  • [30] A 2035 Clinical Research Vision and Roadmap for High-Risk Neuroblastoma
    Moreno, Lucas
    Dubois, Steven G.
    Bird, Nicholas
    Knox, Leona
    Ludwinski, Donna
    Pearson, Andrew D. J.
    Beck-Popovic, Maja
    Bagatell, Rochelle
    PEDIATRIC BLOOD & CANCER, 2025,